 RATIONALE: Analyzing genes that are present in cancer cells may be useful as a method for predicting the response of non-Hodgkins lymphoma to cancer treatment. Imaging procedures such as positron emission tomography PET scans may improve the ability to measure how well cancer has responded to treatment. 